Back to Search Start Over

Primary hyperparathyroidism: Dynamic postoperative metabolic changes.

Authors :
Kaderli, Reto M.
Riss, Philipp
Geroldinger, Angelika
Selberherr, Andreas
Scheuba, Christian
Niederle, Bruno
Source :
Clinical Endocrinology. Jan2018, Vol. 88 Issue 1, p129-138. 10p.
Publication Year :
2018

Abstract

Objective Little is known about the natural changes in parathyroid function after successful parathyroid surgery for primary hyperparathyroidism. The association of intact parathyroid hormone ( iPTH) and calcium (Ca) with 'temporary hypoparathyroidism' and 'hungry bone syndrome' ( HBS) was evaluated. Design Potential risk factors for temporary hypoparathyroidism and HBS were evaluated by taking blood samples before surgery, intra-operatively, at postoperative day ( POD) 1, at POD 5 to 7, in postoperative week ( POW) 8 and in postoperative month ( POM) 6. Patients Of 425 patients, 43 (10.1%) had temporary hypoparathyroidism and 36 (8.5%) had HBS. Measurements The discriminative ability of iPTH and Ca on POD 1 for temporary hypoparathyroidism and HBS. Results Intact parathyroid hormone (IPTH) on POD 1 showed the highest discriminative ability for temporary hypoparathyroidism (C-index = 0.952), but not for HBS. IPTH was helpful in diagnosing HBS between POD 5 and 7 (C-index = 0.708). Extending the model by including Ca resulted in little improvement of the discriminative ability for temporary hypoparathyroidism (C-index = 0.964) and a decreased discriminative ability for HBS (C-index = 0.705). Normal parathyroid metabolism was documented in 139 (32.7%) patients on POD 1 and in 423 (99.5%) 6 months postoperatively, while 2 (0.5%) patients had persistent hyperparathyroidism, one diagnosed between POD 5 and 7 and another at POW 8. No patients suffered from permanent hypoparathyroidism. Conclusions The necessity for Ca and vitamin D3 substitution cannot be predicted with certainty before POD 5 to 7 without serial laboratory measurements. Based on the results, a routine 8-week course of Ca and vitamin D3 treatment seems reasonable and its necessity should be evaluated in a follow-up study. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03000664
Volume :
88
Issue :
1
Database :
Academic Search Index
Journal :
Clinical Endocrinology
Publication Type :
Academic Journal
Accession number :
126850575
Full Text :
https://doi.org/10.1111/cen.13476